See also this year's filing and all EDGAR filings for this company.
PDF Report 0001048477_2017_Biomarin_Pharmaceutical_INC.pdf
Logs
| warning | Large missing amount for aggregate "Revenues" added to remainder. | industry.us_generic | {'missing_ratio': 2.0, 'aggregate_val': -1116854000, 'exp_sum': 1116854000, 'exp_to_value': {'remainder_Revenues': 1116854000}} |
| warning | Large missing amount for aggregate "Expenses" added to remainder. | industry.us_generic | {'missing_ratio': 2.630510148141688, 'aggregate_val': 2331107000, 'exp_sum': 642088000, 'exp_to_value': {'CostOfGoodsAndServicesSold': 209620000, 'SellingGeneralAndAdministrativeExpense': 476593000, 'ResearchAndDevelopmentExpense': 661905000, 'remainder_Expenses': -706030000}} |
| warning | Expenses in unusual place in relation to revenue | input.sec.calculation_linkbase.edgar_model_mapping | {'expenses_node': 'CostsAndExpenses', 'revenue_node': 'Revenues', 'net_inc_node': 'NetIncomeLoss'} |
Graph
Absolute values for 0001048477, Biomarin Pharmaceutical INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 1,421,791,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 750,819,000 |
| 2 | PropertyPlantAndEquipmentNet | 798,768,000 |
| 3 | remainder_Assets | 1,052,312,000 |
| 4 | LiabilitiesCurrent | 439,310,000 |
| 5 | LiabilitiesNoncurrent | 42,034,000 |
| 6 | remainder_Liabilities | 776,071,000 |
| 7 | CostOfGoodsAndServicesSold | 260,975,898 |
| 8 | SellingGeneralAndAdministrativeExpense | 559,917,603 |
| 9 | ResearchAndDevelopmentExpense | 703,454,232 |
| 10 | remainder_Expenses | -129,062,552 |
| 11 | remainder_Revenues | 741,732,779 |
| 12 | remainder_NetIncome | -5,594,168 |
| 13 | remainder_ComprehensiveNetIncome | -7,855,199 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 4,023,690,000 |
| 1 | Liabilities | 1,257,415,000 |
| 2 | Expenses | 1,395,285,181 |
| 3 | Revenues | 741,732,779 |
| 4 | StockholdersEquity | 2,766,275,000 |
| 5 | NetIncome | -659,146,570 |
| 6 | ComprehensiveNetIncome | -663,074,170 |
| 7 | BaseVar | 3,715,786,164 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.03 |
| 9 | EconomicCapitalRatio | 3.05 |
Edgar->Model Mapping
Feature Distribution
Change over Time
